Subsense emerges from stealth

Tetiana Aleksandrova’s bid to commercialize inhalable electrodes

Earlier this year in February, Tetiana Aleksandrova’s Subsense emerged from stealth mode with $17 million in seed funding. This Palo Alto startup is building inhalable BCI technology. Yes, you will ideally be able to inhale nanoparticles that bind to their intended receptors in the brain. They will communicate with an external headset.

They initially plan to treat neurodegenerative diseases, but will eventually use their BCI to control devices and prosthetics. We explored micrometer-sized electrodes in our last few posts. This appears to be the first commercial version.

Here is their roadmap:

The founder and CEO, Tetiana, used to lead Neiry, an EEG company in Russia. Recording nanoparticles are no doubt more exciting and transcendent. If this succeeds, it should be a wake-up call to pay more attention to non-Western BCI labs and innovators.

A BCI like this would eliminate most of the downsides of invasive electrodes without sacrificing the recording and stimulating resolution. It would be by far the easiest BCI to use, not requiring surgery or an annoying EEG headset digging into your scalp.

Read more on their website.